Evidence map›Paper›PMID 39048913›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2024

SARS-CoV-2 reinfection rate before and after VOC Omicron emergence: a retrospective study in Brazil.

Paula Luize Camargos Fonseca, Frederico Scott Varella Malta, Isabela Braga-Paz, Joice do Prado Silva, Carolina Senra Alves de Souza, Renato Santana de Aguiar, Danielle A G Zauli, Renan Pedra de Souza

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paula Luize Camargos FonsecaLaboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Frederico Scott Varella MaltaDepartamento de Pesquisa & Desenvolvimento, Hermes Pardini/Grupo Fleury, Belo Horizonte, Brazil.
Isabela Braga-PazLaboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Joice do Prado SilvaDepartamento de Pesquisa & Desenvolvimento, Hermes Pardini/Grupo Fleury, Belo Horizonte, Brazil.
Carolina Senra Alves de SouzaLaboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Renato Santana de AguiarLaboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Danielle A G ZauliDepartamento de Pesquisa & Desenvolvimento, Hermes Pardini/Grupo Fleury, Belo Horizonte, Brazil.
Renan Pedra de SouzaLaboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. renanpedra@gmail.com.ORCID http://orcid.org/0000-0002-9479-4432

Funding

CAPES Finance Code 001CNPq (315592/2021-4, INCT-One CNPq 405786/2022-0FAPEMIG BPD-00820-22FINEP 0494/20 01.20.0026.00Instituto Todos pela Saúde - ITpS Chamada 01/2021 - C1294Rede Corona-ômica BR MCTI/FINEP affiliated with RedeVírus/MCTI (1227/21)World Health Organization 001
6 · The paper itself

Abstract

SARS-COV-2 reinfection has been reported worldwide, although its rate remains unclear. VOC Omicron's emergence and its sub-variants led to an unprecedented number of COVID-19 cases in several countries, raising concerns regarding reinfection rates. 324,979 RT-qPCR-confirmed positive cases (72.57% from Minas Gerais State) diagnosed between April 1, 2020, and August 31, 2022, at the Hermes Pardini, Grupo Fleury (Brazil) were used to estimate the reinfection rate. Instances of reinfection were characterized by two positive tests occurring with a minimum interval of 60 days. We identified 11,669 cases of reinfection. The states of Minas Gerais, São Paulo, Rio de Janeiro and Goiás represented almost 41% of the reinfections. Up until epidemiological week 46 of 2020, only 14 cases of reinfection were recorded. The majority of reinfections, totalling 6,316 cases, were detected during the circulation period of the Omicron and its sublineages BA.1 and BA.2. Another 4,273 reinfections occurred during the circulation period of sublineages BA.4 and BA.5, revealing two distinct groups of observations. The first group comprised cases of reinfection with a shorter time interval (two infections within a period of up to 200 days), while the second group was associated with a longer time interval (two infections within a period of more than 500 days). The reinfection rate during this period was nearly 8%, which is six times higher than the rate observed at the beginning of the study. In conclusion, our study underscores the dynamic nature of SARS-CoV-2 reinfections and their correlation with emerging variants such as Omicron.

Indexed as

COVID-19ReinfectionSARS-CoV-2AdolescentAdultAgedBrazilFemaleHumansMaleMiddle AgedRetrospective StudiesYoung AdultMolecular diagnosisReal-world evidenceVOC GammaVOC Omicron

Identifiers

PMID39048913
PMCPMC11711811

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.